◆ 会议时间:2018年2月3-4日
◆ 会议地点:美国 好莱坞
◆ 下届会议:2019年临床肿瘤介入研讨会(CIO_2019)
◆ 会议简介:
临床肿瘤介入研讨会(CIO)以其独创性、实践性和注重于改善患者的护理而闻名,重点介绍当前最可行和最受欢迎的肿瘤治疗方法,是那些希望低成本向专家学习的人们必须参加的研讨会。
For 10 years, CIO has served as the premier arena for practical education in the expanding field of interventional oncology. There simply is no comparison. Unconventional and unexpected, this is where leading minds gather, where breakthroughs are shared and boundaries are pushed. There is an IO “Aha” in every session, at every turn.
THE HIGHLIGHTS
==The Year in Review in IO
==Liver-Directed Therapy
==The Role of Y90
==Renal Cell Carcinoma
==Lung Ablation
==Musculoskeletal Interventions
==Interventions for Prostate and Pancreatic Cancer
==Thyroid and Lymph Node Ablation
==Building an IO Practice
==Understanding IO Trial Data
2018 ISET/CIO REGISTRATION RATES
|
Early Bird:
6/15/17-10/27/17 |
Advance:
10/28/17-1/19/18 |
Regular/Onsite:
1/20/18-2/7/18 |
PHYSICIAN |
MVP: CIO & ISET |
$1,499 |
$1,699 |
$1,749 |
CIO Only |
$549 |
$749 |
$799 |
NURSE/ALLIED HEALTH PROFESSIONAL |
MVP: CIO & ISET |
$599 |
$599 |
$599 |
CIO Only |
$249 |
$249 |
$299 |
FELLOW/RESIDENT/STUDENT |
MVP: CIO & ISET |
$699 |
$699 |
$749 |
CIO Only |
$199 |
$249 |
$299 |
INDUSTRY/NON-CLINICAL
(Please note that if you are employed by industry, you MUST register as Industry/Non-Clinical.) |
MVP: CIO & ISET |
$1,699 |
$1,799 |
$1,799 |
CIO Only |
$649 |
$849 |
$949 |
MILITARY/VA |
MVP: CIO & ISET |
$699 |
$699 |
$749 |
CIO Only |
$199 |
$249 |
$299 |
PROGRAM DATES
===CIO Saturday, February 3 – Sunday, February 4
===ISET Saturday, February 3 – Wednesday, February 7
===ISET-Focused Symposia Saturday, February 3 – Wednesday, February 4
===ISET and CIO: Two Program Savings
Saturday, February 3 – Wednesday, February 7
ISET/CIO REGISTRATION INCLUDES:
===Admission to scientific sessions
===Course materials and access to presentations online
===Access to the Exhibit Hall
===Ticket to the Ultimate Tailgate & Super Bowl Party
===Daily continental breakfast, refreshment breaks and boxed lunch in the Exhibit Hall
◆ 参会对象:
政府代表、医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等。 |